There is no cure or way to delay the onset of Huntington’s disease, a degenerative condition that breaks down nerve cells in the brains, but a new study published in the Lancet Neurology found that a drug known as pridopidine seems well-tolerated in patients.
After thirty years in the investment and public relations field, we
have switched our focus lobbing between American and European
companies facilitating business and licensing opportunities .
Starting in the year 2003 L.G.Zangani, LLC has organized the annual
event "Pharmafinance" in Milano and Roma.
Pharmafinance is unique in its structure and has the ability to expose
opportunities generated offering licensing or developing
Recently we have started the site www.letcombatpain.com creating the
first worldwide site for pain news.
The site also offers an humanitarian tools where individuals or
professionals confronted by unique and rare forms of pain can
communicate with all the members of the group simply sending oneemail.
This ability of having a mass communication tool can also be used to
expose innovative pain products or ideas.
Additionally has also been invited as speaker to several conferences
in Europe to discuss the uniqueness and functionality of his site .